These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16440514)

  • 1. Three cases of substitution errors leading to hyoscine hydrobromide overdose.
    Van Sassenbroeck DK; Hemelsoet DM; Vanwalleghem P; Verstraete AG; Santens P; Monsieurs KG; Buylaert WA
    Clin Toxicol (Phila); 2005; 43(7):861-5. PubMed ID: 16440514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presumed central anticholinergic syndrome from inadvertent intravenous hyoscine hydrobromide (scopolamine) injection.
    Wilden J; Rapeport D
    Anaesth Intensive Care; 2004 Jun; 32(3):419-22. PubMed ID: 15264742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unintentional overdose of hyoscine hydrobromide in a young child.
    Xuereb G; Calleja T; Borg J; Pace D
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32051153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.
    Golding JF; Wesnes KA; Leaker BR
    Br J Clin Pharmacol; 2018 Jul; 84(7):1535-1543. PubMed ID: 29522648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Hyperthermia and diminished consciousness in an elderly woman following an accidental overdose of scopolamine.
    Van de Velde K; Siau B; Vermeulen G
    Acta Neurol Belg; 2015 Sep; 115(3):517-8. PubMed ID: 25395072
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.
    Golding JF; Stott JR
    Br J Clin Pharmacol; 1997 Jun; 43(6):633-7. PubMed ID: 9205824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
    Tytgat GN
    Drugs; 2007; 67(9):1343-57. PubMed ID: 17547475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimuscarinic intoxication resulting from the ingestion of moonflower seeds.
    DeFrates LJ; Hoehns JD; Sakornbut EL; Glascock DG; Tew AR
    Ann Pharmacother; 2005 Jan; 39(1):173-6. PubMed ID: 15572604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scopolamine poisoning among heroin users--New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(22):457-60. PubMed ID: 8622615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide.
    Hugel H; Ellershaw J; Gambles M
    J Palliat Med; 2006 Apr; 9(2):279-84. PubMed ID: 16629557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient.
    Murphy D; Waldron D; Kennedy G; Molony J
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e953-e956. PubMed ID: 36379687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).
    Cozanitis DA
    Anaesthesist; 1977 Dec; 26(12):649-50. PubMed ID: 603022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic of poisoning caused by scopolamine disguised as Rohypnol tablets.
    Vallersnes OM; Lund C; Duns AK; Netland H; Rasmussen IA
    Clin Toxicol (Phila); 2009 Nov; 47(9):889-93. PubMed ID: 19821638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hyoscine-related oesophagitis.
    Philcox S; Keegan A
    Med J Aust; 2007 Jun; 186(12):650-1. PubMed ID: 17576184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
    Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
    J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine.
    Hamilton RJ; Perrone J; Hoffman R; Henretig FM; Karkevandian EH; Marcus S; Shih RD; Blok B; Nordenholz K
    J Toxicol Clin Toxicol; 2000; 38(6):597-608. PubMed ID: 11185966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.
    Back IN; Jenkins K; Blower A; Beckhelling J
    Palliat Med; 2001 Jul; 15(4):329-36. PubMed ID: 12054150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oesophageal spasm, vomiting and hyoscine hydrobromide patch.
    Murray-Brown F; Davies IL
    BMJ Support Palliat Care; 2016 Mar; 6(1):125-7. PubMed ID: 26667134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety update: hyoscine hydrobromide patches and serious anticholinergic adverse effects.
    Drug Ther Bull; 2023 Sep; 61(9):134. PubMed ID: 37536750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.